Showing posts with label CIPLA. Show all posts
Showing posts with label CIPLA. Show all posts

Tuesday, July 31, 2012

CIPLA LTD - FIRST QUARTER RESULTS - Q1 FY 2012-13 - TOTAL INCOME UP 24%YoY; NPT UP 58% YoY;



CIPLA LTD

FIRST QUARTER RESULTS
Q1 FY 2012-13

CIPLA LIMITED has released its results for the first quarter ending June, 2012.

1      Net Sales  for Q1 FY 13 stands at Rs.1917.38 Cr; up by 5.7% from Q4.FY 12 (Rs.1814.05 Cr); and up by 23.68% from Q1 FY 12 (Rs.1550.33 Cr) ; and up proportionately (i.e., Q1 FY 13 x 4 vs FY 12) from FY 12 Total by  12.66% (Rs.6807.68 Cr).

        Other Operating Income for Q1 FY 13 stands at Rs.40.81 Cr; down by     -20.79% from Q4.FY 12 (Rs.51.52 Cr); and up by 25.88% from Q1 FY 12 (Rs.32.42 Cr) ; and up proportionately (i.e., Q1 FY 13 x 4 vs FY 12) from FY 12 Total by        -3.87% (Rs.169.82 Cr).

        Total income from operations (net)  for Q1 FY 13 stands at Rs.1958.19 Cr; up by 4.96% from Q4.FY 12 (Rs.1865.57 Cr); and up by 23.72% from Q1 FY 12 (Rs.1582.75 Cr) ; and up proportionately (i.e., Q1 FY 13 x 4 vs FY 12) from FY 12 Total by  12.26% (Rs.6977.5 Cr).

2      Expenses 
                                                        
                Cost of materials consumed      for Q1 FY 13 stands at Rs.550.7 Cr; down by -11.63% from Q4.FY 12 (Rs.623.15 Cr); and up by 1.79% from Q1 FY 12 (Rs.541.04 Cr) ; and down proportionately (i.e., Q1 FY 13 x 4 vs FY 12) from FY 12 Total by  -4.26% (Rs.2300.85 Cr).

                Purchases of stock-in-trade for Q1 FY 13 stands at Rs.151.85 Cr; up by 29.31% from Q4.FY 12 (Rs.117.43 Cr); and up by 2.32% from Q1 FY 12 (Rs.148.41 Cr) ; and up proportionately (i.e., Q1 FY 13 x 4 vs FY 12) from FY 12 Total by 9.33% (Rs.555.55 Cr).

                Employee benefits    for Q1 FY 13 stands at Rs.213 Cr; up by 17.02 % from Q4.FY 12 (Rs.182.02 Cr); and up by 24.39% from Q1 FY 12 (Rs.171.23 Cr) ; and up proportionately (i.e., Q1 FY 13 x 4 vs FY 12) from FY 12 Total by 17% (Rs.728.21Cr).

                Depreciation     for Q1 FY 13 stands at Rs.72.82 Cr; up by 3.35% from Q4.FY 12 (Rs.70.46 Cr); and up by 3.66% from Q1 FY 12 (Rs.70.25 Cr) ; and up proportionately (i.e., Q1 FY 13 x 4 vs FY 12) from FY 12 Total by     3.27% (Rs. 282.07 Cr).

                Other expenses  for Q1 FY 13 stands at Rs.472.92 Cr; down by -7.69% from Q4.FY 12 (Rs.512.29 Cr); and up by 23.67% from Q1 FY 12 (Rs.382.42 Cr) ; and up proportionately (i.e., Q1 FY 13 x 4 vs FY 12) from FY 12 Total by 5.11% (Rs.1799.79Cr).

        Total expenses for Q1 FY 13 stands at Rs.1491.16 Cr; down by   -3% from Q4.FY 12 (Rs.1537.25 Cr); and up by 15.4% from Q1 FY 12 (Rs.1292.13 Cr) ; and up proportionately (i.e., Q1 FY 13 x 4 vs FY 12) from FY 12 Total by 5.05% (Rs.5677.71Cr).

3      Profit from operations  for Q1 FY 13 stands at Rs.467.03 Cr; up by 42.25% from Q4.FY 12 (Rs.328.32 Cr); and up by 60.7% from Q1 FY 12 (Rs.290.62 Cr) ; and up proportionately (i.e., Q1 FY 13 x 4 vs FY 12) from FY 12 Total by 43.72% (Rs.1299.79 Cr).

4      Other Income for Q1 FY 13 stands at Rs.53.06 Cr; up by36.23% from Q4.FY 12 (Rs.38.95 Cr); and up by 28.69% from Q1 FY 12 (Rs.41.23 Cr) ; and up proportionately (i.e., Q1 FY 13 x 4 vs FY 12) from FY 12 Total by     43.12 % (Rs.148.3 Cr).
5      Profit before finance costs (3+4)  for Q1 FY 13 stands at Rs.520.09 Cr; up by 41.61% from Q4.FY 12 (Rs.367.27 Cr); and up by 56.72% from Q1 FY 12 (Rs.331.85 Cr) ; and up proportionately (i.e., Q1 FY 13 x 4 vs FY 12) from FY 12 Total by 43.66% (Rs.1448.09 Cr).

6      Finance costs  for Q1 FY 13 stands at Rs.1.09 Cr; down by -51.56% from Q4.FY 12 (Rs.2.25 Cr); and down by  -90.89% from Q1 FY 12 (Rs.11.96 Cr) ; and down proportionately (i.e., Q1 FY 13 x 4 vs FY 12) from FY 12 Total by -83.63% (Rs.26.63 Cr).

7      Profit before tax (5-6)  for Q1 FY 13 stands at Rs.519 Cr; up by 42.18% from Q4.FY 12 (Rs.365.02 Cr); and up by 62.24% from Q1 FY 12 (Rs.319.89 Cr) ; and up proportionately (i.e., Q1 FY 13 x 4 vs FY 12) from FY 12 Total by 46.05% (Rs.1421.46 Cr).

8      *Tax expense   for Q1 FY 13 stands at Rs.118.24 Cr; up by 61.35% from Q4.FY 12 (Rs.73.28 Cr); and up by 77.67% from Q1 FY 12 (Rs.66.55 Cr) ; and up proportionately (i.e., Q1 FY 13 x 4 vs FY 12) from FY 12 Total by     58.98% (Rs.297.5 Cr).

9      Net Profit  after tax (7-8) for Q1 FY 13 stands at Rs.400.76 Cr; up by 37.37% from Q4.FY 12 (Rs.291.74 Cr); and up by 58.19% from Q1 FY 12 (Rs.253.34 Cr) ; and up proportionately (i.e., Q1 FY 13 x 4 vs FY 12) from FY 12 Total by 42.62% (Rs.1123.96 Cr).

10     Paid-up equity share capital (FV Rs.2/share) for Q1 FY 13 stands at Rs.160.58Cr.

12     Basic and Diluted EPS (Rs.) for Q1 FY 13 stands at Rs.4.99; Rs.3.63 for Q4 FY 12; Rs.3.16 for Q1 FY 12; and Rs.14 for the whole of FY 12.

        % of Public holding in the company is 62.97%.

OTHER DETAILS

Income from operations crossed Rs. 2000 cr for the quarter and posted a growth of about 24%. Domestic sales grew by more than 30% and export sales grew by about 18%. Operating margins and profits after tax have increased by more than 47% and 58% respectively.

% of exports to total sales Was 50.2% in Q1 FY 13 compared to 52.7% in Q1 FY 12. But, in absolute terms, exports have grown by 18%.

Material cost has decreased by 5% mainly on account of changes in product mix viz. lower proportion of anti-retrovirals and higher contribution of anti-depressant segment (Escitalopram) coupled with increased realizations. As a result, operating margins have also increased by about 5%.

The increase in staff cost (Rs. 42 cr) is due to annual increments and increase in manpower. Other expenditure has increased by Rs. 91 cr for the quarter on account of increase in marketing expenses, professional fees, travel expenditure, etc. Tax for the current quarter has marginally increased due to higher profits.

        COMMENTS : Overall, CIPLA  has done very well both on Sales front and on Profitability.

*  *  *  E  N  D  *  *  *

Monday, June 13, 2011

CIPLA LTD - RESULTS FOR = Q4 FY 2011 = FY 2011 = NPT BELOW COMPARABLE PERIODS IN Q4 FY 11 AND IN FY 11


Cipla Limited

NSE Symbol             CIPLA

CIPLA LTD has declared its 4th qtr FY 2011 results.

Net Sales for Q4 FY 11 is Rs.1615.22 cr – against Rs.1317.49 cr in Q4 FY 10.The same for FY 11 is Rs.6123.84 Cr – against Rs.5359.52 Cr in FY 10,indicating a healthy increase in sales on qtrly and annual basis.

Total Expenditure is Rs.1436.74 Cr in Q4 FY 11 – against Rs.1166.18 cr in Q4 FY 10. The same for FY 11 is Rs.5234.16 cr – against Rs.4459.59 Cr in FY 10.

Profit from Operations  is Rs.232.46 cr  in Q4 FY 11 – against Rs.   208.51 Cr in Q4 FY 10. The same for FY 11 is Rs.1083.82 cr – against Rs.1165.32 Cr for FY 10. There is a reduction in OPT in  FY 11 compared to FY 10 – due to heavier increase in expenditure.

Profit  before Tax  is Rs.251 cr for Q4 FY 11 – against Rs.348.13 cr for Q4 FY 10. The same for FY 11 is Rs.1158.12 cr – against Rs.1324.99 cr for FY 10. There is a reduction in PBT also in  FY 11 compared to FY 10.

Net Profit after Tax is Rs.214     Cr in Q4 FY 11 – against Rs.275.53 Cr for Q4 FY 10; The same for FY 11 is Rs.967.12 Cr – against Rs.1081.49 Cr for FY 10.

Against a face Value of Rs.2 – the Earning per Share is Rs.2.67 for Q4 FY 11; and Rs.3.43 for Q4 FY 10. The same for FY 11 is Rs.12.05 for FY 11 and Rs.13.69 for FY 10. Thus – overall, CIPLA has produced results below the level of its comparable earlier periods.


RESULTS TABLE :

CIPLA
31-Mar-11
31-Dec-10
30-Sep-10
30-Jun-10
31-Mar-10
Net Sales
161522
150136
157988
142738
131749
Other Operating Income
5398
5231
3547
5238
5720
Increase in SIT /WIP
-6249
-6635
3972
2086
-8872
 Raw Materials
66398
57426
53841
52247
56612
Traded Goods
19831
18793
17057
12690
13342
Employees Cost
13075
13509
13758
13756
9986
Depreciation
6965
6525
6391
5482
4948
Other Expenditure
43654
40456
36251
32137
40602
Total Expenditure
143674
130074
131270
118398
116618
Profit from Operations
23246
25293
30265
29578
20851
Other Income
2035
2569
1664
1675
4508
Interest
181
293
28
11
46
Profit before tax
25100
27569
31901
31242
34813
Tax expense
3700
4300
5600
5500
7260
Net Profit
21400
23269
26301
25742
27553
Face Value (In Rs
2
2
2
2
2
Paid Up Equity
16058
16058
16058
16058
16058
Basic EPS
2.67
2.9
3.27
3.21
3.43
Public holding (%)
62.72
62.6
62.43
62.4
62.38


05-05-2011 Cipla Limited has informed the NSE regarding the standalone Results for the quarter ended on 31-MAR-2011 as follows: Net Sales of Rs. 161522 lacs for quarter ending on 31-MAR-2011 against Rs. 131749 lacs for the quarter ending on 31-MAR-2010. Net Profit / (Loss) of Rs. 21400 lacs for the quarter ending on 31-MAR-2011 against Rs. 27553 lacs for the quarter ending on 31-MAR-2010.

NOTE :

In 2003, the Company received notice of demand from the National Pharmaceutical Pricing Authority, Government of India on account of alleged overcharging in respect of certain drugs under the Drug Price Control Order. This was contested before the jurisdictional High Courts wherein it was held in favour of the Company. The orders were challenged before the Hon'ble Supreme Court by the Government. The Hon'ble Supreme Court by separate orders restored the matter to the jurisdictional High Court for interpreting the Drug Policy on the basis of directions and principles laid down by them and also restrained the Government from taking any coercive action against the Company.  The Company has been legally advised that on the basis of these orders there is no probability of demand crystallising. Hence no provision is considered necessary in respect of notice of demand aggregating to Rs.1230.28 crores (inclusive of interest) for the period July 1995 to April 2009.

*  *  *   E  N  D   *  *  *